SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-136099
Filing Date
2023-05-04
Accepted
2023-05-04 17:20:34
Documents
5
Effectiveness Date
2023-05-04

Document Format Files

Seq Description Document Type Size
1 S-8 d21126ds8.htm S-8 38706
2 EX-5.1 d21126dex51.htm EX-5.1 6420
3 EX-23.1 d21126dex231.htm EX-23.1 1873
4 EX-FILING FEES d21126dexfilingfees.htm EX-FILING FEES 15009
5 GRAPHIC g21126g0502050401582.jpg GRAPHIC 3264
  Complete submission text file 0001193125-23-136099.txt   67765
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271656 | Film No.: 23890026
SIC: 2834 Pharmaceutical Preparations